Literature DB >> 2310231

Polymyositis and cyclosporin A.

J Alijotas, J Barquinero, J Ordi, M Vilardell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2310231      PMCID： PMC1003970          DOI： 10.1136/ard.49.1.66-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Cyclosporin for polymyositis.

Authors:  S van der Meer; J W Imhof; J C Borleffs
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

3.  Cyclosporin for acute dermatomyositis.

Authors:  P Zabel; G Leimenstoll; W L Gross
Journal:  Lancet       Date:  1984-02-11       Impact factor: 79.321

4.  Cyclosporine in the treatment of intractable polymyositis.

Authors:  H S Goei The; P Jacobs; H Houben
Journal:  Arthritis Rheum       Date:  1985-12

Review 5.  Cyclosporine: a new immunosuppressive agent for organ transplantation.

Authors:  D J Cohen; R Loertscher; M F Rubin; N L Tilney; C B Carpenter; T B Strom
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

6.  Azathioprine with prednisone for polymyositis. A controlled, clinical trial.

Authors:  T W Bunch; J W Worthington; J J Combs; D M Ilstrup; A G Engel
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

7.  Side effects of systemic cyclosporine in patients not undergoing transplantation.

Authors:  A G Palestine; R B Nussenblatt; C C Chan
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

8.  Polymyositis--treatment and prognosis. A study of 107 patients.

Authors:  K G Henriksson; P Sandstedt
Journal:  Acta Neurol Scand       Date:  1982-04       Impact factor: 3.209

9.  [Polydermatomyositis in the adult and its management].

Authors:  J Albert; A Lamberti; H Ott; D Wauthier
Journal:  Sem Hop       Date:  1983-02-24
  9 in total
  4 in total

1.  Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.

Authors:  Yasuhiro Shimojima; Takahisa Gono; Kanji Yamamoto; Kenichi Hoshi; Masayuki Matsuda; Kunihiro Yoshida; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2004-03-24       Impact factor: 2.980

Review 2.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

3.  Idiopathic orbital myositis: treatment with cyclosporin.

Authors:  J Sánchez-Román; J M Varela-Aguilar; J Bravo-Ferrer; E Sequeiros Madueño; M Fernández de Bobadilla
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

Review 4.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.